Hyperthyroid: increased risk for thyroid storm (treat with B-blockers, iodine, steroids), difficult airway (from goiter)
Steroids: HPA suppression seen with 20+mg prednisone taken for 3+weeks, give 50-100mg IV hydrocortisone prior to induction, 25-50mg hydrocortisone q8hr for 24-48hr until baseline steroid use is resumed
Anticoagulation
Antiplatelet agents: require 7-10 days to reverse (14% normal platelet function restored per day)
Do not need to discontinue low dose aspirin (ASA 81mg) prior to prostate biopsy, increased risk for minor bleeding
Can perform ureteroscopy and laser prostate surgeries without stopping anticoagulation
If on dual-antiplatelet therapy, try to continue aspirin if possible
Moderate + high risk groups should undergo bridging (not safe to stop)
Cardiac stents: wait 6-12 weeks for bare metal, 12mo for drug-eluting
THE KEY: decision often made on individual patient situation, hematology/cardiology consults are recommended if continuing/stopping medications is unclear
For high risk surgeries (cystectomy, RPLND), recommend preop dose SQH 5KU, discharge home with prophylaxis x4 weeks (recommended by NCCN but not AUA)
References
AUA Core Curriculum
Culkin, Daniel J., et al. "Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper." The Journal of urology 192.4 (2014): 1026-1034.
Naik, Rishi, et al. "The role of extended venous thromboembolism prophylaxis for major urological cancer operations." BJU international 124.6 (2019): 935-944.
Stoffel, J. T., et al. "Optimizing outcomes in urologic surgery: preoperative care for the patient undergoing urologic surgery or procedure." (2019).
Violette, Philippe D., et al. "Guideline of guidelines: thromboprophylaxis for urological surgery." BJU international 118.3 (2016): 351-358.
Wieder JA: Pocket Guide to Urology. Sixth Edition. J.Wieder Medical: Oakland, CA, 2021.